We are live on
!
Find out more
AF
Avanza Fonder Portfolio holdings
AUM
$4.59B
1-Year Est. Return
41.03%
This Fund
S&P 500
This Quarter
Est. Return
-4.89%
1 Year Est. Return
+41.03%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.05B
AUM Growth
-$320M
(-9.5%)
Cap. Flow
-$135M
Cap. Flow
% of AUM
-4.44%
Top 10 Holdings %
Top 10 Hldgs %
40.33%
Holding
468
New
31
Increased
49
Reduced
321
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$20.2M |
| 2 |
Accenture
ACN
|
+$14.8M |
| 3 |
Medtronic
MDT
|
+$11M |
| 4 |
Chubb
CB
|
+$7.13M |
| 5 |
Trane Technologies
TT
|
+$7.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$21.5M |
| 2 |
NVIDIA
NVDA
|
+$19.3M |
| 3 |
Amazon
AMZN
|
+$14.6M |
| 4 |
Apple
AAPL
|
+$11.2M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$8.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.06% |
| 2 | Consumer Discretionary | 14.72% |
| 3 | Financials | 13.56% |
| 4 | Healthcare | 12.28% |
| 5 | Communication Services | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Quest Resource Holding
QRHC
$26.3M
| $54.5K | ﹤0.01% |
20,584
-2,544
| -11% | -$12K |
|
452
CryoPort
CYRX
$774M
| $51K | ﹤0.01% |
8,281
| – | – |
|
453
Core & Main
CNM
$8.67B
| $50.9K | ﹤0.01% |
999
-903
| -47% | -$46.8K |
|
454
Prime Medicine
PRME
$549M
| $42.8K | ﹤0.01% |
23,918
+1,438
| +6% | +$3.67K |
|
455
Trex
TREX
$5.17B
| $39K | ﹤0.01% |
650
-272
| -30% | -$17.7K |
|
456
Verra Mobility
VRRM
$848M
| $37.2K | ﹤0.01% |
1,596
-1,477
| -48% | -$35.6K |
|
457
Corbus Pharmaceuticals
CRBP
$177M
| $37.2K | ﹤0.01% |
7,150
| – | – |
|
458
Shimmick
SHIM
$171M
| $35.2K | ﹤0.01% |
20,000
| – | – |
|
|
AUTL
459
Autolus Therapeutics
AUTL
$495M
| $33.4K | ﹤0.01% |
21,276
-10,494
| -33% | -$21.3K |
|
460
Cabaletta Bio
CABA
$444M
| $21.8K | ﹤0.01% |
17,605
| – | – |
|
461
Descartes Systems
DSGX
$6.57B
| – | – |
-1,035
| Closed | -$169K |
|
|
FOLD
462
DELISTED
Amicus Therapeutics
FOLD
| – | – |
-16,652
| Closed | -$157K |
|
|
MRSN
463
DELISTED
Mersana Therapeutics
MRSN
| – | – |
-2,252
| Closed | -$80.5K |
|
464
SoFi Technologies
SOFI
$23.7B
| – | – |
-65,427
| Closed | -$1.01M |
|
465
Unity
U
$15.5B
| – | – |
-32,569
| Closed | -$732K |
|
|
AMPS
466
DELISTED
Altus Power
AMPS
| – | – |
-52,325
| Closed | -$213K |
|
|
ITCI
467
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-3,043
| Closed | -$254K |
|
|
AZPN
468
DELISTED
Aspen Technology Inc
AZPN
| – | – |
-1,700
| Closed | -$424K |
|
Similar funds
SCM
AG
LNWTC
SV
ANTB
SCM
DWM
VCM
Avanza Fonder's Q1 2025 Portfolio in Review
As of Q1 2025, Avanza Fonder held 468 positions worth $3.05B, down 9.5% from $3.37B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Avanza Fonder withdrew a net $135M in Q1 2025, closing 8 positions and reducing 321 holdings. Its most notable exit was SoFi Technologies, an estimated $1.01M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Avanza Fonder opened a new position in Linde worth $21.1M.
- Avanza Fonder's largest Q1 2025 buy was Linde: 44,860 shares worth $21.1M.
- Avanza Fonder added most to Tesla in Q1 2025, an estimated $3.07M increase.
- Avanza Fonder's biggest Q1 2025 reduction was Microsoft, cutting an estimated $21.5M.
- Avanza Fonder fully exited SoFi Technologies in Q1 2025, selling an estimated $1.01M.
- Avanza Fonder's ten largest holdings make up 40% of its $3.05B portfolio in Q1 2025.
- Avanza Fonder opened 31 new positions and closed 8 in Q1 2025.
- Avanza Fonder's portfolio value fell 9.5% quarter-over-quarter to $3.05B.
Based on Avanza Fonder's 13F filing for Q1 2025, filed 15 Apr 2025.